Barely Significant
← all excerpts

Clinical benefits of <i>Bifidobacterium infantis</i> YLGB-1496 in modulating gut microbiota and immunity in young children.

Front Nutr · 2025 · PMC12812959 · PMID 41561177

Europe PMCDOI
1
hedged sentence
0.0570
closest p · 1.1× alpha
0.0570
boldest claim

The sentences

a strong trendp = 0.057so close (0.05 < p ≤ 0.1)
Furthermore, fecal IgA, which was initially lower in the probiotic group, showed a strong trend toward increase relative to the placebo ( p = 0.057), suggesting a bolstering of mucosal immunity over the intervention period.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.